PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PolyPid Ltd. (Nasdaq: PYPD) will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference in Miami Beach, FL, on March 14, 2024. The management team will also engage in one-on-one investor meetings during the event.
02/28/2024 - 07:00 AM
PETACH TIKVA, Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Company management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference taking place in Miami Beach, FL, March 12 – 14, 2024.
Barclays 26 th Annual Global Healthcare Conference Fireside Chat
Date: Thursday, March 14, 2024 Time: 7:30 – 7:55 AM ET
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid around the conference should contact their Barclays representative.
About PolyPid
PolyPid Ltd. (Nasdaq: PYPD ) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn .
Contacts: IR@Polypid.com
Investors: britchie@lifesciadvisors.com
When is PolyPid Ltd. participating in the fireside chat at the Barclays 26th Annual Global Healthcare Conference?
PolyPid Ltd. will participate in the fireside chat on Thursday, March 14, 2024.
Where is the Barclays 26th Annual Global Healthcare Conference taking place?
The conference will be held in Miami Beach, FL.
What is the ticker symbol for PolyPid Ltd.?
The ticker symbol is PYPD.
What type of company is PolyPid Ltd.?
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes.
What should investors do if they want to meet with PolyPid during the conference?
Investors interested in meeting with PolyPid should contact their Barclays representative.
PYPD Rankings
N/A Ranked by Stock Gains
PYPD Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Surgical and Medical Instrument Manufacturing
About PYPD
polypid®, a specialty pharmaceutical company, develops and manufactures products based on its plex™ technology. so far, 70 patients have been treated in clinical trials with polypid’s anti-infection products demonstrating safety and efficacy. polypid is in the process of submitting its lead product for phase-iii trial in the us and eu. plex™ is able to optimize drugs' therapeutic performance and clinical outcomes. plex™-based protected drug reservoir is implanted directly into the body’s target area thus enabling prolonged delivery of drugs, over periods ranging from days to several months. polypid’s pipeline focuses on 3 products: d-plex™ - intended for prevention and treatment of surgical infections caused by bacteria. its effectiveness is currently being tested in patients undergoing open-heart surgery, with a view to preventing infections that may occur following surgery. the product is currently undergoing clinical studies at several medical centers. bonypid®-1000 - designed to e
